Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Marc Olesen, Leroy Hood, Paul Flicek, and Adam Siepel


DNANexus has appointed Marc Olesen to serve as president and chief operating officer.

Prior to joining DNANexus Olesen served as senior vice president and general manager of network and cloud security for McAfee. He also served as vice president of software-as-a-service for Mercury Interactive, which was acquired
during his tenure by Hewlett-Packard.

Olesen holds an AB in economics and an MS in industrial engineering from Stanford University.

Omicia has tapped Leroy Hood, the president and co-founder of the Institute for Systems Biology, and Paul Flicek, a team leader and senior scientist at the European Bioinformatics Institute, to serve on its scientific advisory board.

Adam Siepel, an associate professor of biological statistics and computational biology at Cornell University, has received a Guggenheim fellowship from the John Simon Guggenheim Memorial Foundation.

Siepel has developed tools that have been used in the identification of recombinant strains of HIV, the discovery of new human genes, and the characterization of the non-protein-coding regions of mammalian genomes.

He was one of 181 artists, scientists, and scholars chosen to receive fellowships from about 3,999 applications as part of the foundation’s 88th annual competition for the US and Canada.

Siepel will use the fellowship to support a sabbatical leave for the 2012-13 academic year, to be spent in Cambridge, UK, where he will work at the European Bioinformatics Institute.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.